TickerKhojComparison · NSE · data 2026-11-02
Bal Pharma Limited vs Quest Laboratories Ltd.
In plain words
Size: Quest Laboratories Ltd. is about 1 times the market value of Bal Pharma Limited.
Valuation (P/E): Bal Pharma Limited 17.5 vs Quest Laboratories Ltd. 9.
Return on equity: Quest Laboratories Ltd. 16.7% vs Bal Pharma Limited 7.9%.
Profit growth over 3 years: Quest Laboratories Ltd. 43.4% a year vs Bal Pharma Limited 34.7% a year.
Debt to equity: Bal Pharma Limited 2.03 vs Quest Laboratories Ltd. 0.08.
Differences in the numbers, not a recommendation of either stock.
Side by side
| BALPHARMA | QUESTLAB | |
|---|---|---|
| Price | ₹79.25 | ₹82 |
| Market cap | ₹129 cr | ₹134 cr |
| P/E | 17.5 | 9 |
| P/B | — | 1.4 |
| ROE | 7.9% | 16.7% |
| ROCE | 19.2% | 19.3% |
| Debt / equity | 2.03 | 0.08 |
| Operating margin | 6.7% | 15.6% |
| Dividend yield | 1.48% | 0.00% |
| Sales growth, 3 years (yearly) | 0.8% | 22.0% |
| Profit growth, 3 years (yearly) | 34.7% | 43.4% |
| 1-year return | -4.3% | -6.8% |
| Revenue, last 12 months | ₹334 cr | ₹112 cr |
| Net profit, last 12 months | ₹7 cr | ₹15 cr |
| Latest quarter | Jun 2026 | — |
| Quarter net profit | ₹1 cr | — |
| Quarter profit vs a year earlier | +433.3% | — |
| Promoter holding | 50.86% | — |
| Health check | Average (6.1/10) | Strong (7.3/10) |
Common questions
Which has a higher P/E, Bal Pharma Limited or Quest Laboratories Ltd.?
Bal Pharma Limited trades at the higher P/E (17.5 against 9). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which earns a higher return on equity?
Quest Laboratories Ltd. (16.7% against 7.9%).
Which carries more debt?
Bal Pharma Limited has the higher debt-to-equity ratio (2.03 against 0.08).